Status:
UNKNOWN
Influence of Inhaler Compliance on the Treatment of Asthma Patients
Lead Sponsor:
Taipei Medical University Hospital
Collaborating Sponsors:
Taipei Medical University
Conditions:
Pulmonary Disease
Asthma
Eligibility:
All Genders
20-80 years
Brief Summary
The major goal of "Influence of Inhaler Compliance on the Treatment of Asthma Patients" is to explore compliance rate outcome in adult asthmatic patients (20-80 years old) with mild to moderate persis...
Detailed Description
1. Upon enrollment, the all patients will be educated and equipped with asthma supportive kits, which is a electronic device attaches to an MDI medicine. 2. The asthma supportive kit registers every p...
Eligibility Criteria
Inclusion
- Adult asthmatic patients (20-80 years old)
- With mild to moderate persistent asthma according to ATS definition and diagnosis
- Willing to use Budesonide+Formoterol.
- Adequately use inhaler
- Without evident intentional non-adherence
- Agree asthma is a common and potentially serious chronic disease
- Willing to sign Informed Consent Form
Exclusion
- Inadequately use inhaler
- Disagree asthma is a common and potentially serious chronic disease
- With uncontrolled systemic diseases, such as hypertension, heart failure, renal failure, de-compensated liver cirrhosis, etc.;
Key Trial Info
Start Date :
August 14 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 31 2024
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT06108908
Start Date
August 14 2019
End Date
August 31 2024
Last Update
October 31 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Taipei Medical University, Taiwan, R.O.C.
Taipei, Taiwan